Healthcare -
Medical - Devices - NASDAQ - US
$ 9.34
-1.37 %
$ 259 M
Market Cap
-7.59
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
ZimVie Inc.
| Net Income | -25.8 M |
| Depreciation & Amortization | 34.3 M |
| Capital Expenditures | -6.68 M |
| Stock-Based Compensation | 16.6 M |
| Change in Working Capital | 0 |
| Others | -6.66 M |
| Free Cash Flow | 7.49 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||
| Net Income | (25.8) | (393.3) | (63.9) | (95.3) | (179.0) | (27.9) | (459.4) |
| Depreciation & Amortization | 34.3 | 121.7 | 122.8 | 129.7 | 134.3 | 135.1 | 147.7 |
| Deferred Income Tax | (4.2) | (17.1) | (70.4) | (22.1) | (22.8) | (18.6) | (28.0) |
| Stock Based Compensation | 16.6 | 27.0 | 30.3 | 7.3 | 5.9 | 7.1 | 5.6 |
| Other Operating Activities | (6.7) | 295.7 | 4.5 | 213.0 | 142.0 | 268.6 | 411.7 |
| Change in Working Capital | 0 | 3.1 | 1.3 | 44.7 | 5.6 | 23.5 | 84.4 |
| Cash From Operations | 14.2 | 37.1 | 24.6 | 64.3 | 86.0 | 119.2 | 162.0 |
| INVESTING CASH FLOW | |||||||
| Capital Expenditures | (6.7) | (12.5) | (26.5) | (56.6) | (38.3) | (53.0) | (48.3) |
| Other Items | 289.0 | (2.7) | (2.1) | (3.7) | (11.2) | (31.6) | (2.0) |
| Cash From Investing Activities | 282.3 | (15.2) | (28.7) | (60.3) | (49.5) | (84.6) | (50.3) |
| FINANCING CASH FLOW | |||||||
| Common Stock Repurchased | 0 | 0 | (1.1) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (290.0) | (24.5) | 536.5 | (16.9) | (0.7) | 0 | (38.6) |
| Dividends Paid | 0 | 0 | (540.6) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.7) | (3.4) | 2.8 | 89.2 | (45.8) | (43.7) | (58.7) |
| Cash From Financing Activities | (294.7) | (25.7) | (1.3) | 72.3 | (46.5) | (43.7) | (97.3) |
| CHANGE IN CASH | |||||||
| Net Change In Cash | (11.2) | (1.8) | (10.8) | 73.0 | (9.6) | (9.3) | 13.1 |
| FREE CASH FLOW | |||||||
| Free Cash Flow | 7.5 | 24.7 | (1.9) | 7.7 | 47.7 | 66.2 | 113.7 |